Lakshmi S. Yarlagadda
Oncology
10660 Park Road
Suite 2100
Charlotte, NC 28210
Suite 2100
Charlotte, NC 28210
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Journal: American journal of hematology
Published: July 04, 2022
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Journal: American journal of hematology
Published: January 25, 2022
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Journal: Journal of clinical medicine
Published: January 06, 2022
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
Journal: Cancers
Published: July 06, 2021
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Journal: Haematologica
Published: April 12, 2021
Showing 1-5 of 5
Last Updated: 09/26/2026